Novartis AG (NOVNEE)
SIX
Closed
Oct 9, 2026
Day's Range
118.6252 wk Range
97.18Overview - NOVNEE - Novartis AG
Key Statistics
Valuation
Enterprise Value
223.60B
P/E (Trailing)
‪21.31‬
Price / Sales (TTM)
‪4.11‬
Price / Book
‪6.65‬
EV / EBITDA
‪11.68‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Price stats
Beta
‪0.49‬
50-Day Avg
‪123.62‬
200-Day Avg
‪121.39‬
Market Cap - NOVNEE - Novartis AG
Peers - NOVNEE - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- NOVNEESIXNovartis AG233.29BMarket Cap+17.54%52-week change21.32P/E (Trailing)‪22.50%‬Profit Margin
- LLYSIXEli Lilly and Company873.52BMarket Cap+40.21%52-week change39.22P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson538.49BMarket Cap+22.72%52-week change31.23P/E (Trailing)‪21.48%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- ROSIXRoche Holding AG283.48BMarket Cap+14.67%52-week change23.21P/E (Trailing)‪19.60%‬Profit Margin
- NOVNSIXNovartis AG Registered Shares227.70BMarket Cap+17.32%52-week change21.94P/E (Trailing)‪22.50%‬Profit Margin
- GILDSIXGilead Sciences, Inc.154.47BMarket Cap+16.63%52-week change18.69P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - NOVNEE - Novartis AG
About
Novartis AG is a global healthcare company based in Switzerland, specializing in the research and development of pharmaceutical products. Functioning at the forefront of the medical innovation landscape, Novartis is dedicated to discovering new ways to improve and extend people’s lives. The company is predominantly…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
